Abstract
Of 14 patients with obsessive-compusive disorder who entered an 8-week open trial of buspirone, none improved. The ineffectiveness of buspirone may shed light on the serotonergic hypothesis that has been proposed for this disorder.

This publication has 8 references indexed in Scilit: